title: Treating to the Target of Das28 < 2.6 in Rheumatoid Arthritis: the Impact of Efficacy on Cost Effectiveness.
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: E
authors.initials: E
authors.lastname: Alemao
authors.affiliation: Parexel International, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Johal
authors.affiliation: Erasmus University, Rotterdam, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Al
authors.affiliation: Erasmus University, Rotterdam, The Netherlands.
authors.forename: Mölken M
authors.initials: MM
authors.lastname: Rutten-van